Medicare Products is a subsidiary of the Polyco Healthline Group, which combines 85 years’ expertise of in providing protection and hygiene products and services in the workplace.
From our Group’s state-of-the-art warehouse and laboratory testing facility in Lincolnshire, our expert teams drive research and development and maintain logistics and customer service levels to ensure just-in-time supply.
Designing, sourcing, licensing, and selling products, we optimise every step across the global supply chain. We innovate in partnership with businesses and manufacturers to overcome our customers biggest challenges and to ensure a more compliant and safer environment.
Our expertise touches every point along the supply chain, including manufacturers, distributors, retailers and end-users. By mastering efficient routes to market and optimising logistics, our agile network stretches across multiple channels, countries and distribution bases.
Medicare Products’ business is organised into two areas:
Both areas are supported by central functions such as Finance, Supply Chain, Customer Services, Human Resources and Technical departments.
Our supply chain includes the sourcing of both raw materials and finished goods for the medical and professional markets.
We are working collaboratively with our suppliers to eradicate forced labour and ill treatment of employees within our supply chains. We are committed in acting ethically in all social and environmental aspects and our Group anti-slavery and social accountability policies reflects this.
We believe that it is important to act with integrity in our business relationships and take all reasonable and practical steps (including factory and warehouse inspections and audits) to ensure that our standards are being implemented throughout the businesses of our suppliers and that all relevant local legislation and international regulations are complied with. This involves:
Our social accountability management system is largely based upon on these principles, and we manage our system in line with the LSAS methodology (Labour Standards Assurance Systems). LSAS was introduced by NHS
Supply Chain in conjunction with the Department of Health and industry bodies to provide an extra level of corporate, social and ethical governance with regards to labour standards within the supply chain. There are four levels of compliance, we have achieved level 3. We are committed to ensuring that our supply chain partners and contractors throughout the supply chain are equally committed to promote fundamental human rights. We encourage complete transparency from our suppliers, supporting them where necessary to improve practices, however, we have a zero tolerance of slavery and human trafficking.
The minimum standards we require which have been adopted from the Ethical Trading Initiative (ETI) Base Code include the following:
We take all reasonable and practical steps (including factory and warehouse inspections and audits) to ensure that our standards are being implemented throughout the businesses of our suppliers and that all relevant local legislation and international regulations are complied with. This involves:
To ensure a high level of understanding of the risks of modern slavery and human trafficking in our supply chains and our business, we provide training to relevant members of staff. This includes training from International Associates (https://www.ia-uk.com/) who continue to provide us with updates on the subject and continued review and support from the National Health Service Labour Standards Assurance system.
We use the following key performance indicators (KPIs) to measure how effective we have been to ensure that slavery and human trafficking is not taking place in any part of our business or supply chains:
Due diligence with regards to human rights and social accountability is integral to the management programmes that address potential risks and implement improvement.
This statement is made pursuant to section 54(1) of the Modern Slavery Act 2015 and constitutes our slavery and human trafficking statement.
Should any concerns arise, or suspicious activity be noted then these need to be reported to our Head Office (enquiries@medicareproducts.com) and shall be treated in complete confidence.
This statement has been approved by our Board of Directors, who will review and update it as necessary on an annual basis.